ADO 0.00% 2.6¢ anteotech ltd

predictions for end of 2014, page-13

  1. 3,740 Posts.
    lightbulb Created with Sketch. 106
    Gotta agree with Twin again, the biotech space is notoriously hard to predict in terms of time lines. Delays are the rule of thumb and the concern has to be that the SP has risen rapidly in expectation of near term news that might not appear as expected.

    Although a massive announcement could come at any time, I think people have to temper their expectations a little. I've always thought April is too soon for the complete picture to emerge, equally I'd be worried if no progress is announced by June but even this is just gut feeling. I find the tech so compelling and results announced so far so impressive that I'm happy to stay in ADO regardless. Their in house range of products could grow enough to cover costs, further reducing time pressure.

    My Ticks and Tocks are a little slower maybe...
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.